Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Upstart Holdings Inc (UPST) Price & Performance

Novartis AGTrade
Upstart Holdings IncTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Upstart Holdings Inc — how do they compare? Novartis AG trades at $152.33 (market cap $295.37B), while Upstart Holdings Inc trades at $30.01 (market cap $2.91B). The key difference: Novartis AG is far larger — about 101.5× Upstart Holdings Inc's market cap, and Novartis AG pays a 3.07% dividend while Upstart Holdings Inc pays none. Which is the better fit depends on your goals.

NVSUPST
Market Cap
$295.37B$2.91B
Sector
HealthFinancials
52-Week High
$168.62$73.76
52-Week Low
$119.31$24.22
Enterprise Value
$336.69B
Dividend Yield
3.07%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Upstart Holdings Inc

Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.

Read more on UPST